Alaunos Therapeutics, Inc. (TCRT) Total liabilities 2016–2025
Alaunos Therapeutics, Inc. (TCRT) total liabilities at each fiscal year-end, per SEC filings.
$813,000FY2025 · since FY2016: $58.3M → $813,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $813,000 | +17.5% |
| FY2024 | $692,000 | -64.6% |
| FY2023 | $2.0M | -92.6% |
| FY2022 | $26.4M | -28.3% |
| FY2021 | $36.8M | +64.6% |
| FY2020 | $22.4M | — |
| FY2018 | $9.5M | -83.8% |
| FY2017 | $58.4M | +0.2% |
| FY2016 | $58.3M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TCRT financial trends
TCRT RevenueTCRT Net incomeTCRT Net marginTCRT Gross profitTCRT Gross marginTCRT Operating incomeTCRT Operating marginTCRT Operating cash flowTCRT Free cash flowTCRT Capital expendituresTCRT Return on equityTCRT Stock buybacksTCRT Dividends paidTCRT Total assetsTCRT Shareholders’ equityTCRT overview →